Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Onasemnogene‐abeparvovec administration to premature infants with spinal muscular atrophy

Annals of Clinical and Translational Neurology(2024)10.1002/acn3.52213Source: DataRank Database

Onasemnogene‐abeparvovec administration to premature infants with spinal muscular atrophy is a research paper published in Annals of Clinical and Translational Neurology (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.09)OA: goldTopics (68)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Aparna Ajjarapu,Divya Ramachandra,Laura Campello Blasco ORCID,Mar Costa‐Roger ORCID,Eduardo F. Tizzano ORCID

Live enrichment

PubMed:39342433 PMC:PMC11572727 OpenAlex:https://openalex.org/W4402951392

National Institute of Neurological Disorders and Stroke

Grant: R35 NS122306

National Institute of Neurological Disorders and Stroke of the National Institutes of Health

Grant: P50NS053672

National Institutes of Health

Grant: 5R35NS122306-03

Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies

National Institutes of Health

Grant: 2P50NS053672-16

Muscular Dystrophy Specialized Research Center

FWCI

3.09

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.52213

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.52213

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.52213

journalhttps://doi.org/10.1002/acn3.52213

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39342433

Fields of Study

Neurogenetic and Muscular Disorders ResearchRNA modifications and cancerCongenital Anomalies and Fetal Surgery03 medical and health sciences0303 health sciences

MeSH Terms

Biological ProductsDiseases in TwinsFemaleHumansInfantInfant, NewbornInfant, PrematureMuscular Atrophy, SpinalRecombinant Fusion ProteinsSurvival of Motor Neuron 1 ProteinSurvival of Motor Neuron 2 Protein

Keywords

Spinal muscular atrophyMedicineSMN1SMA*Food and drug administrationAdverse effectGestationPediatricsPhysiologyInternal medicinePregnancyPharmacologyGenetics570Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapiaRecombinant Fusion ProteinsZolgensmaNeurosciences. Biological psychiatry. NeuropsychiatryAtròfia muscular espinal - Teràpia genèticaDENOMINACIONES DE GRUPOS::personas::Grupos de Edad::lactante::recién nacido::recién nacido prematuroPediatric and Adolescent MedicineInfants prematurs618Muscular Atrophy, SpinalNAMED GROUPS::Persons::Age Groups::Infant::Infant, Newborn::Infant, PrematureAtròfia muscular espinal - Aspectes genèticsENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades de la médula espinal::atrofia muscular espinalnewbornDiseases in TwinsHumansSMATÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::terapia genéticaRC346-429FENÓMENOS Y PROCESOS::fenómenos genéticos::variación genética::mutaciónBiological ProductsOther subheadings::Other subheadings::Other subheadings::/drug therapyANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Genetic TherapyCase StudyInfant, NewbornInfantGenetics and Genomicsgene therapySurvival of Motor Neuron 1 ProteinSurvival of Motor Neuron 2 ProteinAnomalies cromosòmiquesNeurologyPHENOMENA AND PROCESSES::Genetic Phenomena::Genetic Variation::MutationFemaleNeurology. Diseases of the nervous systemDISEASES::Nervous System Diseases::Central Nervous System Diseases::Spinal Cord Diseases::Muscular Atrophy, SpinalInfant, PrematureRC321-571

Sustainable Development Goals

SDG 0: Good health and well-being